LAM-X: revolutionary wound-treating nanomaterials

Congratuations to LAM-X, a.s. – the newest company launched by i&i Prague!

Story of LAM-X technology is a perfect example of our work in i&i Prague. For the last year our expert Investment manager Barbora Šumová (https://www.iniprague.com/about/team/) entered project called LAM-X: light activated nanomaterials providing protection from bacteria, viruses and other patogenes. In cooperation with the university of origin (Charles University, Prague and CUIP) and the inventor doc. RNDr. Jiří Mosinger, PhD., Barbora helped LAM-X reach all milestones, build a proper business plan, set up a functional team and, finally, launched this advanced technology as a Start-up. Company itself was established on 20th February 2020.

LAM-X is now a fully functional biotechnology company, it´s lead product is a nanomembrane that generates singlet oxygen upon activation by visible light. The clinical study on patients suffering from ulcers proved the efficacy of the LAM-X membrane. This platform technology can be used in the fight against infections that are caused by surface-transmitted pathogens found in hospitals, sanitation facilities, food and water production factories. Unlike antibiotics, which target specific cell parts, the singlet oxygen approach is quick and rather nonspecific, making it impossible for microbes to develop resistance mechanism. It can provide solution in countries, where sanitary conditions complicate even the simpliest medical interventions as well as it answers the general demand for non-antibiotic treatment, too.

“At LAM-X we believe that by protecting our environment from harmful microbes, we are able to reduce the number of unnecessary life-threatening complications.”

TO LEARN MORE:

https://lam-x.tech/

https://www.linkedin.com/company/lam-x/about/

 

 

 

*to find out more about our investment and acceleration process, search: https://www.iniprague.com/investment-process/